Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
90.15m
Last Price
$2.80
52-Week Range
$2.07 - $4.20
04/24/2025 02:59 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808